Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection
Launched by GILEAD SCIENCES · Oct 28, 2015
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Key Inclusion Criteria:
- • Adult patients with chronic genotype 1 HCV infection with or without compensated cirrhosis
- • Patients who are prescribed Harvoni
- Key Exclusion Criteria:
- • None
- • Note: Other protocol defined Inclusion/Exclusion criteria may apply.
About Gilead Sciences
Gilead Sciences is a leading biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines to address unmet medical needs. With a strong emphasis on antiviral therapies, particularly for HIV, hepatitis B, hepatitis C, and influenza, Gilead leverages advanced research and development capabilities to drive breakthroughs in treatment and care. The company is committed to improving patient outcomes through rigorous clinical trials, fostering collaborations with healthcare professionals, and engaging in partnerships to enhance global health. Gilead's dedication to scientific excellence and patient-centric approaches positions it at the forefront of the biopharmaceutical industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shinagawa Ku, , Japan
Bunkyo Ku, , Japan
Sapporo Shi, , Japan
Shinjuku Ku, , Japan
Yokohama Shi, , Japan
Kobe Shi, , Japan
Yonago Shi, , Japan
Koto Ku, , Japan
Minato Ku, , Japan
Osakasayama Shi, , Japan
Nerima Ku, , Japan
Koriyama Shi, , Japan
Sumida Ku, , Japan
Sendai Shi, , Japan
Koshigaya Shi, , Japan
Osaka Shi, , Japan
Fukuoka Shi, , Japan
Hiroshima Shi, , Japan
Nagoya Shi, , Japan
Ageo Shi, , Japan
Hamamatsu Shi, , Japan
Kuki Shi, , Japan
Matsuyama Shi, , Japan
Toyama Shi, , Japan
Kawasaki Shi, , Japan
Morioka Shi, , Japan
Kumamoto Shi, , Japan
Nagasaki Shi, , Japan
Amagasaki Shi, , Japan
Asahi Shi, , Japan
Asahikawa Shi, , Japan
Chichibu Shi, , Japan
Fujioka Shi, , Japan
Fukui Shi, , Japan
Iizuka Shi, , Japan
Inzai Shi, , Japan
Iwaki Shi, , Japan
Izunokuni Shi, , Japan
Kanazawa Shi, , Japan
Kirishima Shi, , Japan
Kitamoto Shi, , Japan
Kure Shi, , Japan
Moriguchi Shi, , Japan
Nagakute Shi, , Japan
Nakagami Gun, , Japan
Nishinomiya Shi, , Japan
Ogi Shi, , Japan
Okayama Shi, , Japan
Ota Ku, , Japan
Sasebo Shi, , Japan
Tokorozawa Shi, , Japan
Tokushima Shi, , Japan
Wakayama Shi, , Japan
Yachiyo Shi, , Japan
Chuo Shi, , Japan
Hakodate Shi, , Japan
Handa Shi, , Japan
Inashiki Gun, , Japan
Iruma Gun, , Japan
Kamogawa Shi, , Japan
Karatsu Shi, , Japan
Kashiwa Shi, , Japan
Kawagoe Shi, , Japan
Kodaira Shi, , Japan
Kurume Shi, , Japan
Kyoto Shi, , Japan
Miyazaki Shi, , Japan
Saitama Shi, , Japan
Sakai Shi, , Japan
Shimotsuke Shi, , Japan
Tagawa Shi, , Japan
Toyoake Shi, , Japan
Utsunomiya Shi, , Japan
Yanagawa Shi, , Japan
Chiba Shi, , Japan
Akita Shi, , Japan
Aomori Shi, , Japan
Arao Shi, , Japan
Asakura Shi, , Japan
Gifu Shi, , Japan
Hashima Shi, , Japan
Hatsukaichi Shi, , Japan
Higashiibaraki Gun, , Japan
Hirosaki Shi, , Japan
Hitachi Shi, , Japan
Hukui Shi, , Japan
Ichikawa Shi, , Japan
Ikeda Shi, , Japan
Ise Shi, , Japan
Izumo Shi, , Japan
Kagoshima Shi, , Japan
Kashihara Shi, , Japan
Kasukabe Shi, , Japan
Kawaguchi Shi, , Japan
Kitakyushu Shi, , Japan
Kofu Shi, , Japan
Komae Shi, , Japan
Komaki Shi, , Japan
Kuga Gun, , Japan
Kurashiki Shi, , Japan
Maebashi Shi, , Japan
Matsumoto Shi, , Japan
Niigata Shi, , Japan
Noshiro Shi, , Japan
Obihiro Shi, , Japan
Oita Shi, , Japan
Omihachiman Shi, , Japan
Otsu Shi, , Japan
Oume Shi, , Japan
Saga Shi, , Japan
Sano Shi, , Japan
Shimonoseki Shi, , Japan
Shimotsuga Gun, , Japan
Shirakawa Shi, , Japan
Shizuoka Shi, , Japan
Shunan Shi, , Japan
Takamatsu Shi, , Japan
Takasaki Shi, , Japan
Toda Shi, , Japan
Tonami Shi, , Japan
Ureshino Shi, , Japan
Yamagata Shi, , Japan
Yatsushiro Shi, , Japan
Yokkaichi Shi, , Japan
Yoshida Gun, , Japan
Patients applied
Trial Officials
Gilead Study Director
Study Director
Gilead Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials